Beck, A. H. 2004. The Flexner Report and the standardization of American medical education. Journal of the American Medical Association 291(17):2139-2140.

Bester, A. 2011. The importance of food safety in Africa. How We Made It in Africa. (accessed June 14).

Bogdanich, W., and J. Hooker. 2007. From China to Panama, a trail of poisoned medicine. New York Times, May 6.

Bogdanich, W., J. Hooker, H. Kumar, A. Giridharadas, and J. Ali Manik. 2007. As FDA tracked poisoned drugs, a winding trail went cold in China. New York Times, June 17.

Branigan, T. 2008. Chinese figures show fivefold rise in babies sick from contaminated milk. Guardian, December 2.

Bren, L. 2006. The road to the biotech revolution: Highlights of 100 years of biologics regulation. FDA Consumer Magazine. (accessed October 25, 2011).

Dangerous imports. 2011. New York Times, June 25.

FDA (Food and Drug Administration). 2010. About FDA: What we do. (accessed March 1, 2012).

———. 2011a. FDA’s international posts: Improving the safety of imported food and medical products. (accessed November 22, 2011).

———. 2011b. Pathway to global product safety and quality. Washington, DC: U.S. Food and Drug Administration.

FDA Subcommittee on Science and Technology. 2007. FDA science and mission at risk: Report of the Subcommittee on Science and Technology. Washington, DC: FDA.

Finch, L. 1999. Soothing syrups and teething powders: Regulating proprietary drugs in Australia, 1860-1910. Medical History 43(1):74-94.

Flexner, A. 1910. Medical education in the United States and Canada. New York: The Carnegie Foundation for the Advancement of Teaching.

GAO (Government Accountability Office). 2008a. Drug safety: Better data management and more inspections are needed to strengthen FDA’s foreign drug inspection program. GAO-08-970. Washington, DC: GAO.

———. 2008b. Medical devices: Challenges for FDA in conducting manufacturer inspections. GAO-08-428T. Washington, DC: GAO.

———. 2010a. Drug safety: FDA has conducted more foreign inspections and begun to improve its information on foreign establishments but more progress is needed. GAO-10-961. Washington, DC: GAO.

———. 2010b. Food and Drug Administration: Response to heparin contamination helped protect public health; controls that were needed for working with external entities were recently added. GAO-11-95. Washington, DC: GAO.

———. 2011. Drug safety: FDA faces challenges overseeing the foreign drug manufacturing supply chain. GAO-11-936T. Washington, DC: GAO.

Gill, L. 2011 March 2. Addressing the challenges of medical device safety in a global environment. Presented at Strengthening Core Elements of Regulatory Systems in Developing Countries: Meeting One, Institute of Medicine, Washington, DC.

Harris Interactive. 2008. Confidence in FDA hits new low, according to Interactive study. (accessed November 30, 2011).

HHS (Department of Health and Human Services). 2011. The global health strategy of the U.S. Department of Health and Human Services. Washington, DC: HHS.

Jackson, L. S. 2009. Chemical food safety issues in the United States: Past, present, and future. Journal of Agriculture and Food Chemistry 57(18):8161-8170.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement